Olema Pharmaceuticals, Inc. (OLMA)
14.06
+0.10
(+0.72%)
USD |
NASDAQ |
May 21, 16:00
14.08
+0.02
(+0.14%)
After-Hours: 19:59
Olema Pharmaceuticals Research and Development Expense (TTM) : 176.30M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| CytomX Therapeutics, Inc. | 68.10M |
| Protagonist Therapeutics, Inc. | 170.14M |
| Cogent Biosciences, Inc. | 277.48M |
| Disc Medicine, Inc. | 188.43M |
| Nuvalent, Inc. | 316.16M |